Market highlights for next week: Major earnings releases

Monday, July 21

Theravance, Inc. (NASDAQ: THRX)'s PDUFA date for Telavancin for the treatment of complicated skin infections.
Merck & Co., Inc. (NYSE: MRK) to report Q2 earnings; conference call at 9:00am.
Bank of America Corporation (NYSE: BAC) to report Q2 earnings; conference call at 9:30am.
Apple, Inc. (NASDAQ: AAPL) to report Q3 earnings; conference call at 5:00pm.
Texas Instruments Incorporated (NYSE: TXN) to report Q2 earnings; conference call at 5:30pm.

Tuesday, July22

United Parcel Services, Inc. (NYSE: UPS) to report Q3 earnings; conference call at 8:30am.
Halliburton Company (NYSE: HAL) to report Q2 earnings; conference call at 9:00am.
Caterpillar Inc. (NYSE: CAT) to report Q2 earnings; conference call at 11:00am.
Lockheed Martin Corporation (NYSE: LMT) to report Q2 earnings; conference call at 11:00am.
Yahoo!, Inc. (NASDAQ: YHOO) to report Q2 earnings; conference call at 5:00pm.

Wednesday, July 23

Amgen, Inc. (NASDAQ: AMGN)'s PDUFA date rescheduled from 4/23. Management's submission to FDA of robust risk management plan after FDA ODAC panel meeting was considered by FDA as major amendment to Nplate's BLA causing 3-month review extension according to current PDUFA rules.
AT&T, Inc. (NYSE: T) to report Q2 earnings; conference call at 10:00am.
The Boeing Company (NYSE: BA) to report Q2 earnings; conference call at 10:30am.
PepsiCo, Inc. (NYSE: PEP) to report Q2 earnings; conference call at 11:00am.
McDonald's Corporation (NYSE: MCD) to report Q2 earnings; conference call at 1:00pm.
Amazon.com, Inc. (NASDAQ: AMZN) to report Q2 earnings; conference call at 5:00pm.

Thursday, July 24

The Dow Chemical Company (NYSE: DOW) to report Q2 earnings; conference call at 10:00am.
Southwest Airlines Co. (NYSE: LUV) to report Q2 earnings; conference call at 12:30pm.

Friday, July 25

CV Therapeutics, Inc. (NASDAQ: CVTX)'s PDUFA date for supplemental New Drug Application, sNDA and New Drug Application, NDA, for Ranolazine (Ranexa).
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA)'s and Titan Pharmaceuticals (AMEX: TTP)'s PDUFA date for Fanapta (Iloperidone), a serotonin/dopamine receptor blocking agent for treating Schizophrenia.
Eisai Co., Ltd. (OTC: ESALY) and MGI Pharma's PDUFA date for Aquavan injection (Fospropofol Disodium Injection), a sedative-hypnotic agent in patients undergoing diagnostic or therapeutic procedure.
Schering-Plough Corporation (NYSE: SGP)'s PDUFA date for Organon Asenapine for the treatment of schizophrenia.

Tags: aquavan, eisai, fanapta, organon asenapine, OrganonAsenapine, ranolazine, telavancin, theravance, titan pharmaceuticals, TitanPharmaceuticals